Hypothyroidism is a Predisposing Factor for Fenofibrate Induced Rhabdomyolysis - Patient Report and Literature Review
- 1 September 2007
- journal article
- case report
- Published by Walter de Gruyter GmbH in Drug Metabolism and Drug Interactions
- Vol. 22 (4) , 279-284
- https://doi.org/10.1515/dmdi.2007.22.4.279
Abstract
A literature survey reveals that both lipid lowering drugs - statins and fibrates--and hypothyroidism are documented causes of muscle disorders including rhabdomyolysis leading to acute renal failure. We describe a case of fenofibrate monotherapy (Lipicard) induced dialysis dependent acute renal failure in an undiagnosed hypothyroid patient which is the first case to be reported from Sri Lanka. We strongly recommend that all patients who are receiving statins and/or fibrates should be screened for occult hypothyroidism which seems to aggravate the muscle damage due to the above drugs, with or without other risk factors.Keywords
This publication has 6 references indexed in Scilit:
- Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering DrugsJAMA, 2004
- Rhabdomyolysis and Renal Failure Associated with Gemfibrozil MonotherapyAnnals of Pharmacotherapy, 2004
- Acute renal failure in a hypothyroid patient with rhabdomyolysisClinical Nephrology, 2003
- Fenofibrate Monotherapy Induced RhabdomyolysisDiabetes Care, 2003
- Rhabdomyolysis in a Patient with HypothyroidismEndocrine Journal, 2003
- Rhabdomyolysis and Acute Renal Failure in a Patient with Hypothyroidism.Internal Medicine, 1993